Long-Term Effects of Ozone Treatment in Patients with Persistent Numbness and Tingling Secondary to Chemotherapy-Induced Peripheral Neuropathy. A Retrospective Study
Open Access
- 11 January 2025
- journal article
- research article
- Published by SAGE Publications in Integrative Cancer Therapies
- Vol. 24
Abstract
Background: Numbness and tingling secondary to chemotherapy-induced peripheral neuropathy (CIPN) are frequent side effects that limit chemotherapy treatment and quality of life. Successful treatments for CIPN are limited. This preliminary report shows the potential long-term effects of ozone treatment in the management of persistent numbness and tingling secondary to CIPN. Methods: Ozone treatment was administered by rectal insufflation in 15 patients (female/male: 8/7, age: 66 years old) suffering from persistent numbness and tingling secondary to grade-2 or grade-3 CIPN. Planned ozone treatment consisted of 40 sessions over 4 months. The initial concentration of 10 μg/mL was progressively increased to 30 μg/mL. The initial gas volume of 180 mL/session was progressively increased to 300 mL/session if tolerated. Before and after ozone treatment, and at 3- and 6- months after the end of treatment, they were assessed (i) the grade of CIPN-toxicity, and (ii) the self-reported decrease in numbness and tingling. Results: After ozone treatment, 47% of patients experienced a decrease in the grade of CIPN-toxicity ( P = .016), and 67% of patients reported a decrease in numbness and tingling ≥50% ( P = .002). These effects were maintained at 3- and 6- months after the end of O3T. Conclusions: In this retrospective report, patients with persistent numbness and tingling secondary to CIPN showed clinically relevant and long-term improvements after ozone treatment. The magnitude and duration of the observed effects merit further research and support our ongoing clinical trials.Keywords
Funding Information
- Instituto de Salud Carlos III (PI 19/00458)
- Instituto de Salud Carlos III (PI 23/01324)
- Fundación Canaria Instituto de Investigación Sanitaria de Canarias (ENF22/10)
- Fundación DISA (016/2019)
- Cabildo de Gran Canaria (CIGC2021)
- Fundación Española del Dolor (BF1-19-13)
This publication has 48 references indexed in Scilit:
- Falls, Functioning, and Disability Among Women With Persistent Symptoms of Chemotherapy-Induced Peripheral NeuropathyJournal of Clinical Oncology, 2017
- Pathophysiology of Chemotherapy-Induced Peripheral NeuropathyFrontiers in Molecular Neuroscience, 2017
- AMPK activation by peri-sciatic nerve administration of ozone attenuates CCI-induced neuropathic pain in ratsJournal of Molecular Cell Biology, 2016
- Ozone Therapy in the Management of Persistent Radiation-Induced Rectal Bleeding in Prostate Cancer PatientsEvidence-Based Complementary and Alternative Medicine, 2015
- Is ozone pre-conditioning effect linked to Nrf2/EpRE activation pathway in vivo? A preliminary resultEuropean Journal of Pharmacology, 2014
- Long-Term Control of Refractory Hemorrhagic Radiation Proctitis With Ozone TherapyJournal of Pain and Symptom Management, 2013
- Effect of Duloxetine on Pain, Function, and Quality of Life Among Patients With Chemotherapy-Induced Painful Peripheral NeuropathyJAMA, 2013
- Healthcare Costs and Workloss Burden of Patients with Chemotherapy-Associated Peripheral Neuropathy in Breast, Ovarian, Head and Neck, and Nonsmall Cell Lung CancerChemotherapy Research and Practice, 2012
- Adjuvant Ozonetherapy in Advanced Head and Neck Tumors: A Comparative StudyEvidence-Based Complementary and Alternative Medicine, 2004
- Ozone Selectively Inhibits Growth of Human Cancer CellsScience, 1980